Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials

被引：70

作者：

Diener, HC

Dowson, AJ

Ferrari, M

Nappi, G

Tfelt-Hansen, P

机构：

[1] Univ Essen Gesamthsch, Dept Neurol, D-45122 Essen, Germany

[2] Univ London Kings Coll Hosp, Kings Headache Serv, London, England

[3] Univ Leiden Hosp, Dept Neurol, NL-2300 RC Leiden, Netherlands

[4] Univ Pavia, IRCCS C Mondino, Headache Ctr, I-27100 Pavia, Italy

[5] Glostrup Cty Hosp, DK-2600 Glostrup, Denmark

来源：

CEPHALALGIA | 1999年 / 19卷 / 08期

关键词：

D O I：

10.1046/j.1468-2982.1999.019008699.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：699 / 700

页数：2

共 7 条

[1] Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine:: a multicentre, dose-range finding study [J].

Dahlof, C ;

Diener, HC ;

Goadsby, PJ ;

Massiou, H ;

Olesen, J ;

Schoenen, J ;

Wilkinson, M ;

Sweet, RM ;

Klein, KB .

EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (06) :535-543

[2] 311C90: Increasing the options for therapy with effective acute antimigraine 5HT(1B/1D) receptor agonists [J].

Ferrari, MD .

NEUROLOGY, 1997, 48 (03) :S21-S24

[3]

GERAUD G, IN PRESS CEPHALALGIA

[4] Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine - A multicenter, double-blind, placebo-controlled, dose range-finding study [J].

Rapoport, AM ;

Ramadan, NM ;

Adelman, JU ;

Mathew, NT ;

Elkind, AH ;

Kudrow, DB ;

Earl, NL .

NEUROLOGY, 1997, 49 (05) :1210-1218

[5]

SOLOMON NM, 1997, NEUROLOGY, V9, P1219

[6] Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat [J].

Tfelt-Hansen, P .

CEPHALALGIA, 1998, 18 (08) :532-538

[7] GUIDELINES FOR CONTROLLED TRIALS OF DRUGS IN MIGRAINE .1. EDITION [J].

TFELTHANSEN, P .

CEPHALALGIA, 1991, 11 (01) :1-12

← 1 →